Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia
一项随机II期研究比较了紫杉醇纳米粒联合吉西他滨(加或不加托珠单抗)作为晚期胰腺癌一线治疗方案的疗效:生存率和恶病质
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01965
Chen, Inna M; Johansen, Julia S; Theile, Susann; Silverman, Libbie M; Pelz, Katherine R; Madsen, Kasper; Dajani, Olav; Lim, Kevin Z M; Lorentzen, Torben; Gaafer, Omnia; Koniaris, Leonidas G; Ferreira, Anna C; Neelon, Brian; Guttridge, Denis C; Ostrowski, Michael C; Zimmers, Teresa A; Nielsen, Dorte